Efficacy and safety of monoclonal antibodies in the treatment of relapsing remitting multiple sclerosis: a systematic review

Ana Avedillo-Salas, Laura Baeza Martínez, Ana Fanlo-Villacampa, Jorge Vicente-Romero

Open source

DOI
10.1007/s00415-026-13824-y
Published
2026-04-22
Container
Journal of Neurology
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00415-026-13824-y,
  title = {Efficacy and safety of monoclonal antibodies in the treatment of relapsing remitting multiple sclerosis: a systematic review},
  author = {Ana Avedillo-Salas and Laura Baeza Martínez and Ana Fanlo-Villacampa and Jorge Vicente-Romero},
  year = {2026},
  journal = {Journal of Neurology},
  doi = {10.1007/s00415-026-13824-y},
  url = {https://doi.org/10.1007/s00415-026-13824-y}
}

RIS

TY  - JOUR
TI  - Efficacy and safety of monoclonal antibodies in the treatment of relapsing remitting multiple sclerosis: a systematic review
AU  - Ana Avedillo-Salas
AU  - Laura Baeza Martínez
AU  - Ana Fanlo-Villacampa
AU  - Jorge Vicente-Romero
PY  - 2026
JO  - Journal of Neurology
DO  - 10.1007/s00415-026-13824-y
UR  - https://doi.org/10.1007/s00415-026-13824-y
ER  - 

APA

Avedillo-Salas, A., Martínez, L. B., Fanlo-Villacampa, A., & Vicente-Romero, J. (2026). Efficacy and safety of monoclonal antibodies in the treatment of relapsing remitting multiple sclerosis: a systematic review. Journal of Neurology. https://doi.org/10.1007/s00415-026-13824-y

Source records